nefla mapimod
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for nefla mapimod, covering 2021-10-27 to 2021-10-27. Get the full timeline:
Most recent: Clinical Trial Update: Proof-of-Concept Study of a Selective p38 MAPK Alpha Inhibitor, Neflamapimod, in Subjects With Mild Alzheimer's Disease [Phase 2]